Ovariectomy disregulates osteoblast and osteoclast formation through the T-cell receptor CD40 ligand

Proc Natl Acad Sci U S A. 2011 Jan 11;108(2):768-73. doi: 10.1073/pnas.1013492108. Epub 2010 Dec 27.

Abstract

The bone loss induced by ovariectomy (ovx) has been linked to increased production of osteoclastogenic cytokines by bone marrow cells, including T cells and stromal cells (SCs). It is presently unknown whether regulatory interactions between these lineages contribute to the effects of ovx in bone, however. Here, we show that the T-cell costimulatory molecule CD40 ligand (CD40L) is required for ovx to expand SCs; promote osteoblast proliferation and differentiation; regulate the SC production of the osteoclastogenic factors macrophage colony-stimulating factor, receptor activator of nuclear factor-κB ligand, and osteoprotegerin; and up-regulate osteoclast formation. CD40L is also required for ovx to activate T cells and stimulate their production of TNF. Accordingly, ovx fails to promote bone loss and increase bone resorption in mice depleted of T cells or lacking CD40L. Therefore, cross-talk between T cells and SCs mediated by CD40L plays a pivotal role in the disregulation of osteoblastogenesis and osteoclastogenesis induced by ovx.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Animals
  • CD40 Ligand / metabolism*
  • Coculture Techniques
  • Estrogens / metabolism
  • Humans
  • Ligands
  • Mice
  • NF-kappa B / metabolism
  • Osteoblasts / cytology*
  • Osteoclasts / cytology*
  • Osteoporosis / metabolism
  • Osteoprotegerin / metabolism
  • Ovariectomy / methods
  • T-Lymphocytes / cytology*
  • Tumor Necrosis Factor-alpha / metabolism

Substances

  • Estrogens
  • Ligands
  • NF-kappa B
  • Osteoprotegerin
  • Tumor Necrosis Factor-alpha
  • CD40 Ligand